亿帆医药：因旅行限制 FDA将推迟F-627上市申请批复

格隆汇3月31日丨亿帆医药公告，因旅行限制，FDA将推迟F-627上市申请批复，直到现场检查完成。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.